fluoxetine has been researched along with arachidonic acid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
| Chang, L; Greenstein, D; Klaff, J; Qu, Y; Rapoport, SI; Seemann, R | 1 |
| Bazinet, RP; Chang, L; Ertley, RN; Lee, HJ; Rao, JS; Rapoport, SI | 1 |
| Lee, AK; Low, MJ; Rubinstein, M; Smart, JL; Tse, A | 1 |
| Basselin, M; Blanchard, H; Chang, L; Chen, M; Cheon, Y; Fox, MA; Ma, K; Ramadan, E; Rapoport, SI | 1 |
| Aryal, P; Brennan, PE; Burgess-Brown, NA; Cao, L; Carpenter, EP; Clausen, MV; Dong, L; Dong, YY; Goubin, S; Grieben, M; Mackenzie, A; McClenaghan, C; Mukhopadhyay, S; Pike, AC; Quigley, A; Ruda, GF; Sansom, MS; Tucker, SJ | 1 |
6 other study(ies) available for fluoxetine and arachidonic acid
| Article | Year |
|---|---|
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
Chronic fluoxetine upregulates arachidonic acid incorporation into the brain of unanesthetized rats.
Topics: Amphetamines; Animals; Arachidonic Acid; Autoradiography; Brain; Brain Mapping; Drug Administration Routes; Drug Administration Schedule; Drug Interactions; Fluoxetine; Infusions, Intravenous; Male; Rats; Rats, Inbred F344; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Tritium; Up-Regulation; Wakefulness | 2006 |
Chronic fluoxetine increases cytosolic phospholipase A(2) activity and arachidonic acid turnover in brain phospholipids of the unanesthetized rat.
Topics: Animals; Antidepressive Agents, Second-Generation; Arachidonic Acid; Brain; Cytosol; Fluoxetine; Fluvoxamine; Frontal Lobe; Injections, Intraperitoneal; Male; Phospholipases A; Phospholipids; Rats; Rats, Inbred F344; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Selective Serotonin Reuptake Inhibitors; Up-Regulation | 2007 |
Reciprocal regulation of TREK-1 channels by arachidonic acid and CRH in mouse corticotropes.
Topics: Animals; Arachidonic Acid; Cells, Cultured; Chlorpromazine; Corticotrophs; Corticotropin-Releasing Hormone; Cyclic AMP; Fluoxetine; Green Fluorescent Proteins; Hydrogen-Ion Concentration; Membrane Potentials; Mice; Mice, Transgenic; Neuroprotective Agents; Patch-Clamp Techniques; Potassium Channels, Tandem Pore Domain; Thionucleotides | 2011 |
Transient postnatal fluoxetine leads to decreased brain arachidonic acid metabolism and cytochrome P450 4A in adult mice.
Topics: Animals; Arachidonic Acid; Behavior, Animal; Calcium; Calcium Signaling; Cytochrome P-450 CYP4A; Fluoxetine; Male; Mice; Nerve Tissue Proteins; Selective Serotonin Reuptake Inhibitors; Synaptic Transmission | 2014 |
K2P channel gating mechanisms revealed by structures of TREK-2 and a complex with Prozac.
Topics: Amino Acid Sequence; Arachidonic Acid; Binding Sites; Crystallography, X-Ray; Fluoxetine; Humans; Ion Channel Gating; Models, Molecular; Molecular Dynamics Simulation; Molecular Sequence Data; Potassium; Potassium Channels, Tandem Pore Domain; Protein Conformation; Protein Folding; Protein Structure, Secondary; Protein Structure, Tertiary | 2015 |